Prevalence of Human Immunodeficiency Virus Infection, Mortality Rate, and Serogroup Distribution Among Patients with Pneumococcal Bacteremia at Denver General Hospital, 1984–1994
Pandemics of human immunodeficiency virus (HIV) type 1 infection and penicillin resistance highlight the urgency of preventing invasive pneumococcal disease with vaccination. We characterized pneumococcal serogroup distribution and the mortality rate among 460 patients with pneumococcal bacteremia f...
Saved in:
Published in: | Clinical infectious diseases Vol. 25; no. 2; pp. 195 - 199 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chicago, IL
The University of Chicago Press
01-08-1997
University of Chicago Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pandemics of human immunodeficiency virus (HIV) type 1 infection and penicillin resistance highlight the urgency of preventing invasive pneumococcal disease with vaccination. We characterized pneumococcal serogroup distribution and the mortality rate among 460 patients with pneumococcal bacteremia from 1984 through 1994 at Denver General Hospital and the prevalence of HIV infection in patients for whom pneumococcal bacteremia was diagnosed from 1989 to 1994. Vaccinerelated serogroups accounted for 426 isolates (92.6%), including 48 (92.3%) of 52 isolates from HIVinfected patients. Mortality among patients 15 years of age or older was higher during 1984–1988 (18 [12.9%] of 140) than during 1989–1994 (10 [5.2%] of 191: rate ratio, 2.5; 95% confidence interval, 1.2–5.2). Of patients 15–59 years of age from 1989 to 1994, 44 (39.6%) of 111 men and three (7.3%) of 41 women were HIV-infected. Four (8.5%) of 47 HIV-infected patients and four (3.8%) of 105 other patients in this group died (age-weighted rate ratio, 1.8; 95% confidence interval, 0.5–6.2). We recommend routine screening of young adults with pneumococcal bacteremia for HIV infection and immunization of HIV-infected patients with pneumococcal vaccine (which includes most serogroups of infecting strains). |
---|---|
Bibliography: | ark:/67375/HXZ-BK6QQPM5-5 Reprints or correspondence: Dr. Edward N. Janoff, Veterans Affairs Medical Center, Infectious Disease Section (111F), One Veterans Drive, Minneapolis, Minnesota 55417. istex:009126382F0B09BAA288EE9D6DC0B3866FE1B440 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1086/514538 |